Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals

QR Code

Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals

Little is known about engagement and retention in care of people diagnosed with chronic hepatitis C (HCV) in England. Establishing a cascade of care informs targeted interventions for improving case-finding, referral, treatment uptake and retention in care. Using data from the Sentinel Surveillance...

Full description

Bibliographic Details
Main Authors:	Simmons, Ruth, Ireland, Georgina, Irving, Will, Hickman, Matthew, Sabin, Caroline, Ijaz, Samreen, Ramsay, Mary, Lattimore, Sam, Mandal, Sema
Format:	Article
Published:	Wiley 2017
Online Access:	https://eprints.nottingham.ac.uk/49093/

Similar Items

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection
by: Lattimore, Sam, et al.
Published: (2014)

Development of antiviral strategies for treatment of chronic hepatitis B
by: Seow, Heng Fong, et al.
Published: (2002)

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
by: Hellard, M., et al.
Published: (2012)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
by: Foster, Graham R., et al.
Published: (2016)

Pretreatment lesions on magnetic resonance imaging in patients with hepatitis C virus infection diagnosed with hepatocellular carcinoma after initiating direct-acting antiviral therapy
by: Scott, Robert A., et al.
Published: (2018)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

Understanding hepatitis C intervention success: qualitative findings from the HepCATT study
by: Harris, Magdalena, et al.
Published: (2018)

Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C
by: Mitchell, T., et al.
Published: (2016)

An antiviral composition.
by: Abu Bakar, Fatimah, et al.
Published: (2011)

Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
by: Goutzamanis, S., et al.
Published: (2019)

Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
by: Chan, Huan Keat
Published: (2023)

Circular antiviral RNA
by: Omar, Abdul Rahman, et al.
Published: (2012)

An antiviral to cure patients
by: Tang, Ashley
Published: (2021)

Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial
by: Wade, A., et al.
Published: (2018)

Tingkat penggunaan ubat antiviral
by: Halid, Suzalina
Published: (2022)

The landscape of EdD programmes in England
by: Aldred, Elaine Mary
Published: (2018)

Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales
by: Crosland, Paul, et al.
Published: (2018)

A review with updated perspectives on the antiviral potentials of traditional medicinal plants and their prospects in antiviral therapy
by: Saifulazmi, Nur Fadlin, et al.
Published: (2022)

Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?
by: Abo-zeid, Yasmin, et al.
Published: (2018)

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

“I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals
by: Wright, C., et al.
Published: (2018)

Benchmarking
by: Tan, R., et al.
Published: (2018)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

Chemical constituents and antiviral study of Goniothalamus velutinus
by: Fasihuddin Badruddin,, Ahmad, et al.
Published: (2014)

Cytomegalovirus replication steps and the actions of antiviral drugs
by: Abdullah, Ashwaq Ahmed, et al.
Published: (2018)

The impacts of the residential location on transport energy use: a case study from Ankara
by: Bayazit, Sema
Published: (1997)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Port benchmark
by: Bouabid, Mohamed Hachem
Published: (2014)

Benchmarking for excellence
Published: (2008)

Benchmarking universities
by: Sani, Rozana
Published: (2017)

Move over Nelly: lessons from 30 years of employment-based initial teacher education in England
by: Youens, Bernadette, et al.
Published: (2018)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023)

Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)

Asia is the mine of natural antiviral products for public health.
by: R.R., Hafidh, et al.
Published: (2009)

Antiviral activity of resveratrol against human and animal viruses
by: Abba, Yusuf, et al.
Published: (2015)

Antiviral nanodelivery systems: current trends in acyclovir administration
by: Hassan, Haniza, et al.
Published: (2016)

Cascade style sheets
by: Shah, Asadullah, et al.
Published: (2011)

Differing patterns in thermal injury incidence and hospitalisations among 0-4 year old children from England
by: Baker, Ruth, et al.
Published: (2016)

Differing patterns in thermal injury incidence and hospitalisations among 0–4 year old children from England
by: Baker, Ruth, et al.
Published: (2016)